EHA 2022 Conference Coverage
Lecture Summary - EHA 2022 Improved OS With 1L Brentuximab Vedotin + Chemo in Stage III/IV Classical Hodgkin Lymphoma: 6-Year Analysis of ECHELON-1
By
EHA 2022 Conference Coverage
FEATURING
John Radford
By
EHA 2022 Conference Coverage
FEATURING
John Radford
Login to view comments.
Click here to Login
